Goff Brian, CEO of Agios Pharmaceuticals ($AGIO), sold shares on the open market eight times over the past year, totaling about $2.1 million. His most recent sale occurred on March 2, 2026. These sales rank 3,436th among 11,678 individual insiders in our database, where the average is $8.6 million across roughly 6.4 transactions. Brian made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 8500 | $0.00 | 151,603.0000 | 74,665,003 | 5.94% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 18000 | $0.00 | 18,000.0000 | 74,665,003 | 50.00% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 8500 | $0.00 | 0.0000 | 74,665,003 | 100.00% | 0.01% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Stock options (right to buy) | 174000 | $0.00 | 174,000.0000 | 74,665,003 | 9999.99% | 0.23% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Restricted stock units | 48000 | $0.00 | 48,000.0000 | 74,665,003 | 9999.99% | 0.06% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 5918 | $28.96 | 164,548.0000 | 74,665,003 | 3.47% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 13000 | $0.00 | 170,466.0000 | 74,665,003 | 8.26% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 8267 | $28.96 | 157,466.0000 | 74,665,003 | 4.99% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 18000 | $0.00 | 165,733.0000 | 74,665,003 | 12.18% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 3870 | $28.96 | 147,733.0000 | 74,665,003 | 2.55% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 13000 | $0.00 | 26,000.0000 | 74,665,003 | 33.33% | 0.02% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 12750 | $0.00 | 0.0000 | 74,496,287,000 | 100.00% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 6230 | $27.09 | 143,103.0000 | 74,496,287,000 | 4.17% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 12750 | $0.00 | 149,333.0000 | 74,496,287,000 | 9.33% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 12473 | $27.09 | 136,583.0000 | 74,496,287,000 | 8.37% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 25528 | $0.00 | 149,056.0000 | 74,496,287,000 | 20.67% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 25528 | $0.00 | 25,528.0000 | 74,496,287,000 | 50.00% | 0.00% |
| Aug. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 22691 | $0.00 | 134,613.0000 | 74,254,956,000 | 20.27% | 0.00% |
| Aug. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 11085 | $36.67 | 123,528.0000 | 74,254,956,000 | 8.23% | 0.00% |
| Aug. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 22691 | $0.00 | 0.0000 | 74,254,956,000 | 100.00% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 25527 | $0.00 | 51,056.0000 | 74,103,192,000 | 33.33% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 25527 | $0.00 | 117,872.0000 | 74,103,192,000 | 27.64% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 12471 | $33.54 | 105,401.0000 | 74,103,192,000 | 10.58% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 12750 | $0.00 | 118,151.0000 | 74,103,192,000 | 12.10% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 6229 | $33.54 | 111,922.0000 | 74,103,192,000 | 5.27% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 12750 | $0.00 | 12,750.0000 | 74,103,192,000 | 50.00% | 0.00% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Goff Brian | Not found | A | Common Stock | 8000 | $0.00 | 23,409.0000 | 103,517,460 | 51.92% | 0.01% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Goff Brian | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 8500 | $0.00 | 87,292.0000 | 73,372,696,000 | 10.79% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 4153 | $35.54 | 83,139.0000 | 73,372,696,000 | 4.76% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 18000 | $0.00 | 101,139.0000 | 73,372,696,000 | 21.65% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 18000 | $0.00 | 36,000.0000 | 73,372,696,000 | 33.33% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Restricted stock units | 39000 | $0.00 | 39,000.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Stock options (right to buy) | 142500 | $0.00 | 142,500.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 8794 | $35.54 | 92,345.0000 | 73,372,696,000 | 8.69% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 8500 | $0.00 | 8,500.0000 | 73,372,696,000 | 50.00% | 0.00% |
| Aug. 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 22691 | $0.00 | 89,883.0000 | 73,091,490,000 | 33.77% | 0.00% |
| Aug. 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 22691 | $0.00 | 22,691.0000 | 73,091,490,000 | 50.00% | 0.00% |
| Aug. 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 11091 | $42.75 | 78,792.0000 | 73,091,490,000 | 12.34% | 0.00% |
| June 13, 2024 | Intellia Therapeutics, Inc. | $NTLA | Goff Brian | Not found | A | Common Stock | 15409 | $0.00 | 15,409.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Intellia Therapeutics, Inc. | $NTLA | Goff Brian | Not found | A | Stock Option (right to buy) | 22297 | $0.00 | 22,297.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 25527 | $0.00 | 79,307.0000 | 72,967,922,000 | 47.47% | 0.00% |
| June 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 25527 | $0.00 | 76,583.0000 | 72,967,922,000 | 25.00% | 0.00% |
| June 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 12115 | $48.84 | 67,192.0000 | 72,967,922,000 | 15.28% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Stock options (right to buy) | 195500 | $0.00 | 195,500.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 8500 | $0.00 | 17,000.0000 | 72,161,489,000 | 33.33% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Restricted stock units | 54000 | $0.00 | 54,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 4156 | $32.57 | 53,780.0000 | 72,161,489,000 | 7.17% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 8500 | $0.00 | 57,936.0000 | 72,161,489,000 | 17.19% | 0.00% |
| Jan. 24, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 7635 | $21.64 | 49,436.0000 | 72,161,489,000 | 13.38% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 17018 | $0.00 | 102,110.0000 | 72,161,489,000 | 14.29% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 17018 | $0.00 | 57,071.0000 | 72,161,489,000 | 42.49% | 0.00% |
| Jan. 9, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 12066 | $22.99 | 40,053.0000 | 72,161,489,000 | 23.15% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 25527 | $0.00 | 119,128.0000 | 72,161,489,000 | 17.65% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 25527 | $0.00 | 52,119.0000 | 72,161,489,000 | 96.00% | 0.00% |
| Aug. 8, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 22691 | $0.00 | 36,770.0000 | 71,256,118 | 161.17% | 0.03% |
| Aug. 8, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Restricted stock units | 22691 | $0.00 | 45,382.0000 | 71,256,118 | 33.33% | 0.03% |
| Aug. 8, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 10178 | $25.48 | 26,592.0000 | 71,256,118 | 27.68% | 0.01% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Common stock | 25528 | $0.00 | 25,528.0000 | 71,256,118 | 9999.99% | 0.04% |
| June 30, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | S | Common stock | 11449 | $28.36 | 14,079.0000 | 71,256,118 | 44.85% | 0.02% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | M | Performance share units | 25528 | $0.00 | 144,655.0000 | 71,256,118 | 15.00% | 0.04% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Stock options (right to buy) | 94500 | $0.00 | 94,500.0000 | 71,256,118 | 9999.99% | 0.13% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Goff Brian | Chief Executive Officer | A | Restricted stock units | 25500 | $0.00 | 25,500.0000 | 71,256,118 | 9999.99% | 0.04% |